ATXI - Avenue Therapeutics granted extension for Nasdaq compliance March, 15 2024 08:53 AM Avenue Therapeutics Inc. 2024-03-15 08:53:49 ET More on Avenue Therapeutics Avenue Therapeutics signs warrant exercise transactions for $5.0M in proceeds Seeking Alpha’s Quant Rating on Avenue Therapeutics Historical earnings data for Avenue Therapeutics Financial information for Avenue Therapeutics For further details see: Avenue Therapeutics granted extension for Nasdaq compliance